-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DSNM0I+z0tWn5dou0xxFHGpbfHOgRKHi1i2PZ8NJEz+CVKsF89p+H3iAO0MOzo1c 6n2Cgep3bBsM4B6zhfs/sw== 0001179110-08-012078.txt : 20080613 0001179110-08-012078.hdr.sgml : 20080613 20080613103611 ACCESSION NUMBER: 0001179110-08-012078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080611 FILED AS OF DATE: 20080613 DATE AS OF CHANGE: 20080613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gollust Keith R CENTRAL INDEX KEY: 0001325712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 08897311 BUSINESS ADDRESS: BUSINESS PHONE: 781-274-8200 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0202 4 2008-06-11 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325712 Gollust Keith R C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2008-06-11 4 A 0 5398 0 A 44574 D Common Stock 2008-06-11 4 A 0 2699 0 A 47273 D Common Stock 1460970 I By Wyandanch Partners, L.P. Director Stock Option (Right to Buy) 7.03 2008-06-11 4 A 0 5500 0 A 2018-06-11 Common Stock 5500 5500 D Director Stock Option (Right to Buy) 7.03 2008-06-11 4 A 0 2500 0 A 2018-06-11 Common Stock 2500 8000 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2008, December 31, 2008, March 31, 2009 and June 30, 2009, provided the Reporting Person continues to serve as a director of the Issuer on such date. Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2008, December 31, 2008, March 31, 2009 and June 30, 2009, provided the Reporting Person continues to serve as Chairman of the Board of Directors of the Issuer on such date. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The option vests as to 25% of the shares on each of September 30, 2008, December 31, 2008, March 31, 2009 and June 30, 2009, provided the Reporting Person continues to serve as a director of the Issuer on such date. The option vests as to 25% of the shares on each of September 30, 2008, December 31, 2008, March 31, 2009 and June 30, 2009, provided the Reporting Person continues to serve as Chairman of the Board of Directors of the Issuer on such date. /s/ Ann Margaret Eames, Attorney-in-Fact 2008-06-13 -----END PRIVACY-ENHANCED MESSAGE-----